Financial Year |
March 31 2023 |
Monetary Funds |
71,375,168.77 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
17,887,338.40 |
Advances to Suppliers |
4,026.78 |
Other Receivables |
13,249,364.61 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
5,686,819.94 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
465,807.22 |
Total Current Assets |
108,668,525.72 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
899,233,916.79 |
Investment Properties |
3,727,338,600.00 |
Fixed Assetes |
42,965,298.00 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,067,994.72 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,271,971.48 |
Deferred Income Tax Assets |
10,836,461.78 |
Other Non-Current Assets |
965,180.96 |
Sub-Total of Non-Current Assets |
4,743,063,685.70 |
Total Assets |
4,851,732,211.42 |
Short-Term Loans |
9,911,797.50 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
58,532,249.05 |
Accounts Received In Advance |
33,338,838.96 |
Employee Compensation Payable |
3,079,305.90 |
Taxes Payable |
125,620,424.50 |
Interest Payable |
-- |
Dividend Payable |
20,756,165.85 |
Other payables |
429,144,747.04 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
88,917,830.02 |
Other Current Liabilities |
1,063,744.57 |
Sub-Total of Current Liabilities |
770,883,828.97 |
Long-term Loans |
420,040,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
48,093,992.82 |
Special Payable |
-- |
Estimatied Liabilities |
18,759,839.39 |
Deferred Income Tax Liabilities |
377,201,796.90 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
907,152,799.47 |
Total Liabilities |
1,678,036,628.44 |
Paid-In Capital(Or Share Stock) |
749,913,309.00 |
Capital Surplus |
511,280,963.96 |
Surplus Reserve |
130,374,067.84 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,101,835,706.49 |
Minority Stockholder's Interest |
498,350,990.61 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,675,344,592.37 |
Owner's Equity(Stockholder's Equity) |
3,173,695,582.98 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,851,732,211.42 |